Market Exclusive

Analyst Upgrades – Astrazeneca PLC (NYSE:AZN) Stock Gets Upgraded By BNP Paribas from Neutral to Outperform

Analyst Ratings For Astrazeneca PLC (NYSE:AZN)

Today, Astrazeneca PLC (NYSE:AZN) stock received an upgrade by BNP Paribas from Neutral to Outperform.

There are 2 sell ratings, 10 hold ratings, 13 buy ratings on the stock.

The current consensus rating on Astrazeneca PLC (NYSE:AZN) is Hold (Score: 2.44) with a consensus target price of $36.40 per share, a potential 7.34% upside.

Some recent analyst ratings include

Dividend information for Astrazeneca PLC (NYSE:AZN)

Astrazeneca PLC (NYSE:AZN) pays an annual dividend of Community Ranking: with a yield of 4.04% and an average dividend growth of -21.20% based on a 3 Year Average.

Dividend History for Astrazeneca PLC (NYSE:AZN)


Recent Trading Activity for Astrazeneca PLC (NYSE:AZN)
Shares of Astrazeneca PLC closed the previous trading session at with shares trading hands.

Exit mobile version